1YR企业会员
英文名称 | 中文名称 | CAS |
---|---|---|
PF-04691502 | 2-氨基-8-[反式-4-(2-羟基乙氧基)环己基]-6-(6-甲氧基-3-吡啶基)-4-甲基吡啶并[2,3-D]嘧啶-7(8H)-酮 | 1013101-36-4 |
Buparlisib Hydrochloride | BKM120(盐酸盐) | 1312445-63-8 |
Ipatasertib dihydrochloride | (2S)-2-(4-氯苯基)-1-[4-[(5R,7R)-6,7-二氢-7-羟基-5-甲基-5H-环戊并嘧啶-4-基]-1-哌嗪基]-3-[(1-甲基乙基)氨基]-1-丙酮二盐酸盐 | 1396257-94-5 |
Alpelisib | 阿培利司 | 1217486-61-7 |
GSK2636771 | GSK2636771 | 1372540-25-4 |
GDC-0349 | N-ETHYL-N'-[4-[5,6,7,8-四氢-4-[(3S)-3-甲基-4-吗啉基]-7-(3-氧杂环丁基)吡啶并[3,4-D]嘧啶-2-基]苯基]脲 | 1207360-89-1 |
WYE-687 dihydrochloride | WYE-687二盐酸盐 | 1702364-87-1 |
CZC24832 | 5-(2-氨基-8-氟[1,2,4]三唑并[1,5-A]吡啶-6-基)-N-(叔丁基)-3-吡啶磺酰胺 | 1159824-67-5 |
Copanlisib dihydrochloride | Copanlisib | 1402152-13-9 |
BIO-acetoxime | 6-溴靛玉红-3'-丙酮肟 | 667463-85-6 |
FPA-124 | AKT 抗化剂 | 902779-59-3 |
CH5132799 | CH5132799 | 1007207-67-1 |
OTSSP167 hydrochloride | OTSSP 167 盐酸盐 | 1431698-10-0 |
CGK733 | CGK 733 | 905973-89-9 |
KP-23172 | 6H-INDENO[1,2-E]TETRAZOLO[1,5-B][1,2,4]TRIAZIN-6-ONE | 1374996-60-7 |
PI4KIII beta inhibitor 3 | 4-(5-AMINO-2-PYRIDIN-3-YL-THIAZOLO[5,4-D]PYRIMIDIN-7-YL)-PIPERAZINE-1-CARBOXYLIC ACID P-TOLYLAMIDE | 1245319-54-3 |
NU 7026 | 2-(4-吗啉基)-4H-萘并[1,2-B]吡喃-4-酮 | 154447-35-5 |
SAR-260301 | (S)-2-(2-(2-甲基吲哚啉-1-基)-2-氧代乙基)-6-吗啉嘧啶-4(3H)-酮 | 1260612-13-2 |
HS-173 | HS-173 | 1276110-06-5 |
Voxtalisib | VOXTALISIB | 934493-76-2 |
Uprosertib | UPROSERTIB | 1047634-65-0 |
CAL-130 Hydrochloride | 2-[(1S)-1-[(2-氨基-9H-嘌呤-6-基)氨基]乙基]-5-甲基-3-(2-甲基苯基)-4(3H)-喹唑啉酮盐酸盐 | 1431697-78-7 |
LY2090314 | LY 2090314 | 603288-22-8 |
NVP-QAV-572 | N-[2-[2-(2-氟乙基)-2H-四唑-5-基]乙基]-N'-[5-[3-氟-4-(甲基磺酰基)苯基]-4-甲基-2-噻唑基]脲 | 957209-68-6 |
Phenformin hydrochloride | 盐酸苯乙福明 | 834-28-6 |
Pilaralisib | 2-氨基-N-[3-[N-[3-[(2-氯-5-甲氧基苯基)氨基]喹喔啉-2-基]氨基磺酰基]苯基]-2-甲基丙酰胺 | 934526-89-3 |
VS-5584 | VS-5584 | 1246560-33-7 |
CNX-1351 | CNX1351 | 1276105-89-5 |
3CAI | 2-氯-1-(1H-吲哚-3-基)-乙酮 | 28755-03-5 |
ZLN024 hydrochloride | ZLN-024 hydrochloride | 1883548-91-1 |
Seletalisib | UCB5857 | 1362850-20-1 |
CC-223 | CC-223 | 1228013-30-6 |
CC-115 hydrochloride | 1300118-55-1 | 1300118-55-1 |
Duvelisib | IPI-145 | 1201438-56-3 |
Duvelisib (R enantiomer) | 1261590-48-0 | 1261590-48-0 |
Tenalisib | RP6530 | 1639417-53-0 |
mTOR inhibitor-3 | N-乙基-N'-[4-[5,6,7,8-四氢-4-[(3S)-3-甲基-4-吗啉基]-7-(2-嘧啶基)吡啶并[3,4-D]嘧啶-2-基]苯基]脲 | 1207358-59-5 |
KU 59403 | KU59403 | 845932-30-1 |
SC79 | 2-氨基-6-氯-ALPHA-氰基-3-(乙氧羰基)-4H-1-苯并吡喃-4-乙酸乙酯 | 305834-79-1 |
(S)-Ceralasertib | (S)-CERALASERTIB | 1352226-87-9 |
Nemiralisib | CS-2340 | 1254036-71-9 |
BEBT-908 | PI3Kα 抑制剂1 | 1235449-52-1 |
PI4KIIIbeta-IN-9 | 1429624-84-9 | 1429624-84-9 |
SC66 | SC 66 | 871361-88-5 |
VX-984 | 化合物 T11067 | 1476074-39-1 |
Serabelisib | [6-(2-氨基-5-苯并恶唑基)咪唑并[1,2-A]吡啶-3-基]-4-吗啉基甲酮 | 1268454-23-4 |
Borussertib | Borussertib | 1800070-77-2 |
BX517 | PDK1 INHIBITOR | 850717-64-5 |
(R)-PS210 | Propanedioic acid, 2-[(1R)-3-oxo-1-phenyl-3-[4-(trifluoroMethyl)phenyl]propyl]- | 1410101-89-1 |
PF-4989216 | 4-(4-氰基-2-氟苯基)-2-吗啉-5-(1H-1,2,4-三唑-5-基)噻吩-3-腈 | 1276553-09-3 |
Taselisib | GDC 0032 | 1282512-48-4 |
GSK-3 inhibitor 1 | 3-(9-氟-1,2,3,4-四氢吡咯并[3,2,1-JK][1,4]苯并二氮杂卓-7-基)-4-咪唑并[1,2-A]吡啶-3-基-1H-吡咯-2,5-二酮单盐酸盐 | 603272-51-1 |
MP7 | PDK1 抑制剂 | 1001409-50-2 |
Palomid 529 | PALOMID 529 (P529) | 914913-88-5 |
GSK2334470 | GSK2334470 | 1227911-45-6 |
Dactolisib Tosylate | BEZ235 对甲苯磺酸盐 | 1028385-32-1 |
IM-12 | IM-12 | 1129669-05-1 |
AZD8186 | 8-[(1R)-1-[(3,5-二氟苯基)氨基]乙基]-N,N-二甲基-2-(4-吗啉基)-4-氧代-4H-1-苯并吡喃-6-甲酰胺 | 1627494-13-6 |
ON 146040 | 1404231-34-0 | 1404231-34-0 |
ETP-46321 | CS-2500 | 1252594-99-2 |
JNJ-47117096 hydrochloride | 1610536-69-0 | 1610536-69-0 |
(R)-BRD3731 | 2056262-08-7 | |
BRD3731 | 5H-Pyrazolo[3,4-b]quinolin-5-one, 3-(2,2-dimethylpropyl)-1,2,4,6,7,8-hexahydro-4,7,7-trimethyl-4-phenyl-, (4S)- | 2056262-07-6 |
Vps34-IN-2 | (S)-1-(3-methyl-2-oxobutyl)-8-((R)-3-methylmorpholino)-2-(trifluoromethyl)-3,4-dihydro-1H-pyrimido[1,2-a]pyrimidin-6(2H)-one | 1523404-29-6 |
Rheb inhibitor NR1 | 化合物 T16741 | 2216763-38-9 |
Samotolisib | LY-3023414 | 1386874-06-1 |
GSK-3β inhibitor 1 | 2H-Indol-2-one, 1,3-dihydro-3-(2-pyridinylmethylene)-, (3Z)- | 187325-53-7 |
Acalisib | GS-9820 | 870281-34-8 |
GNE-317 | GNE-317 | 1394076-92-6 |
Vps34-IN-1 | VPS34-IN1 | 1383716-33-3 |
Ampkinone | CS-2123 | 1233082-79-5 |
Bimiralisib | PI3K/MTOR抑制剂 | 1225037-39-7 |
AZD-8835 | AZD-8835 | 1620576-64-8 |
AMG319 | AMG319 | 1608125-21-8 |
GNF4877 | GNF4877 | 2041073-22-5 |
Torin 2 | 9-(6-氨基-3-吡啶基)-1-[3-(三氟甲基)苯基]苯并[H]-1,6-萘啶-2(1H)-酮 | 1223001-51-1 |
Idelalisib | 艾代拉里斯 | 870281-82-6 |
VO-Ohpic trihydrate | VO-OHPIC 三水合物 | 476310-60-8 |
GSK-3β inhibitor 2 | GSK-3 β inhibitor 2 | 1702428-31-6 |
KY19382 | KY19382 | 2226664-93-1 |
CCT128930 | CCT128930 | 885499-61-6 |
A66 | A66 | 1166227-08-2 |
BGT226 maleate | NVP-BGT226 | 1245537-68-1 |
AICAR phosphate | 5-氨基-1-核糖基咪唑-4-甲酰胺磷酸盐 | 681006-28-0 |
Deguelin | 魚藤素 | 522-17-8 |
AMG 511 | (R)-4-(2-((5-氟-6-甲氧基吡啶-3-基)氨基)-5-(1-(4-(甲基磺酰基)哌嗪-1-基)乙基)吡啶-3-基)-6-甲基-1,3,5-三嗪-2-胺 | 1253573-53-3 |
TG 100713 | TG 100713,3-(2,4-DIAMINO-6-PTERIDINYL)-PHENOL | 925705-73-3 |
CAY10505 | CAY10505 | 1218777-13-9 |
AS-604850 | 5-[(2,2-二氟-1,3-苯并二恶茂-5-基)亚甲基]噻唑烷-2,4-二酮 | 648449-76-7 |
AS-252424 | 5-[[5-(4-氟-2-羟基苯基)-2-呋喃基]亚甲基]-2,4-噻唑烷二酮 | 900515-16-4 |
MSC2360844 | MSC2360844 | 1305267-37-1 |
MSC2360844 hemifumarate | 1621688-31-0 | |
IM156 | IM156 | 1422365-94-3 |
SRX3207 | 7H-Thieno[3,2-b]pyran-7-one, 3-[4-[[4-[4-(1-azetidinylmethyl)-3-methyl-1H-pyrazol-1-yl]-2-pyrimidinyl]amino]phenyl]-5-(4-morpholinyl)- | 2254693-15-5 |
ATR inhibitor 2 | 2-氨基-6-氟-N-(5-氟-4-(4-(4-(噁丁环烷-3-基)哌嗪-1-羰基)哌啶-1-基)吡啶-3-基)吡唑并[1,5-A]嘧啶-3-甲酰胺 | 1613191-99-3 |
ASP4132 | (6-(1-((6-甲氧基吡啶-3-基)甲基)哌啶-4-基)-1H-苯并[D]咪唑-2-基)(4-(4-(三氟甲基)苄基)哌嗪-1-基)甲酮 双对甲苯磺酸盐 | 1640294-30-9 |
PQR626 | 无中文名称 | 1927857-98-4 |
TMBIM6 antagonist-1 | 1-(2-氨基苯基)-3-(3-硝基苯基)-2-丙烯-1-酮 | 123134-61-2 |
SAR502250 | SAR502250 | 503860-57-9 |
XL388 | [7-(6-氨基-3-吡啶基)-2,3-二氢-1,4-苯并氧氮杂卓-4(5H)-基][3-氟-2-甲基-4-(甲基磺酰基)苯基]-甲酮 | 1251156-08-7 |
联系方式